Operates across three named segments — Hospital Equipment, Tyre/Rim & Wheels, and Footwear — with Hospital Equipment the largest at Rs 22.76 crore of segment revenue in FY26. Tyre/Rim & Wheels brought in Rs 4.58 crore while Footwear was marginal at Rs 0.09 crore. Standalone revenue for FY26 was Rs 51.62 crore, up 10.2% year-on-year, with net profit of Rs 2.62 crore. Materials at 49% of revenue are the largest input cost, followed by other operating expenses at 23.4%. In February 2026, a wholly-owned subsidiary called Krypton Tyres Limited was incorporated to manufacture tyres, marking an expansion of the tyre business. Headquartered in Kolkata and listed only on BSE under code 523550. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Hospital Equipments, Tyre, Rim & Wheels, Footwear. Small, diversified BSE-listed manufacturer across unrelated product lines (medical equipment, automotive components, footwear).
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 44 | 33 | 43 | 47 | 52 |
| EBITDA (ex other income) | 1 | 4 | 5 | 5 | 7 |
| margin % | 1.9 | 11.1 | 10.7 | 11.0 | 13.1 |
| Owners' profit | 1 | 1 | 1 | 0 | 0 |
| EPS, as reported (₹) | 0.48 | 0.69 | 0.80 | 0.06 | 1.78 |
| ROE % · ROCE % | 2.3 · 7.7 | 3.2 · 6.0 | 3.6 · 8.4 | 1.3 · 10.0 | 8.2 · 14.3 |
| Debt / equity (x) | 0.37 | 0.47 | 0.52 | 0.69 | 0.67 |
| Cash from operations | 6 | (1) | 1 | 5 | 12 |
| Capex | (2) | (1) | (1) | (5) | (1) |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11 | 14 | 11 | 13 | 11 | 12 | 13 | 16 |
| Profit before tax | 1 | 4 | 0 | 0 | 1 | 1 | 1 | 2 |
| Net profit | 0 | 3 | 0 | (1) | 1 | 1 | 1 | 1 |
| EPS (₹) | 0.27 | 0.31 | 0.13 | 0.12 | 0.37 | 0.41 | 0.48 | 0.52 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| a) Tyre, Rim & Wheels | 8 | 9.3 |
| b) Footwear | 0 | 0.1 |
| c) Hospital Equipments | 39 | 48.6 |
| a) Tyre, Rim & Wheels * | 1 | 1.0 |
| c) Hospital Equipments * | 16 | 19.4 |
| a. Tyre, Rim & wheels | 7 | 8.5 |
| c. Hospital Equipments | 11 | 13.1 |
| Total, before eliminations | 81 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B |
|---|
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 11 Sept 2026 · Krypton Industries 36th AGM voting results - both resolutions passed | board shareholder meetings | medium | — | — |
| 11 Sept 2026 · Krypton Industries 36th AGM outcome - FY26 accounts adopted, MD re-appointed | board shareholder meetings | low | — | — |
| 20 Aug 2026 · 36th AGM scheduled on 11 September 2026 via video conferencing | compliance | minimal | — | — |
| 17 Aug 2026 · Krypton Industries FY26 Annual Report and 36th AGM Notice on 11 Sept 2026 | board shareholder meetings | medium | — | — |
| 17 Aug 2026 · Krypton Industries 36th AGM on Sept 11, 2026 via video conferencing | board shareholder meetings | low | — | — |
| 14 Aug 2026 · Q1 FY27 results: Net profit up 30% at Rs 71.68 lakhs | results | high | — | — |
| 14 Aug 2026 · Q1 FY27 Results: PAT up 30% at Rs 71.68 lakh; AGM on 11 September | results | high | — | — |
| 14 Aug 2026 · 36th AGM notice published, meeting on Sept 11 via video call | compliance | minimal | — | — |
| 30 Jul 2026 · Public notice on transfer of physical securities published in newspapers | compliance | minimal | — | — |
| 22 Jul 2026 · Board meeting on August 14, 2026 to approve Q1 FY27 results | board shareholder meetings | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| EV/EBITDA |
|---|
| ROE % |
|---|
| ROCE % |
|---|
| Rev CAGR 5y % |
|---|
| EBITDA m. % |
|---|
| GODREJ INDUSTRIES LTD | 38,055 | 32.4 | 1.64 | 14.5 | 10.4 | 6.4 | 19.0 | 27.3 |
| 3M INDIA LIMITED | 36,735 | 60.1 | 17.11 | 42.6 | 27.2 | 35.7 | 6.8 | 21.7 |
| DCM SHRIRAM LIMITED | 15,675 | 10.8 | 2.03 | 10.9 | 11.1 | 9.5 | 11.4 | 11.7 |
| KAMA HOLDINGS LTD. | 7,275 | 7.8 | 0.48 | 1.9 | 12.3 | — | 13.5 | 22.4 |
| BALMER LAWRIE & CO LTD | 2,883 | 10.3 | 1.38 | 7.4 | 13.0 | 11.2 | 12.2 | 14.8 |
| TTK HEALTHCARE LIMITED | 1,576 | 21.3 | 1.41 | — | 5.9 | 7.4 | — | 12.2 |
| EMPIRE INDUSTRIES LTD. | 634 | 12.3 | 1.80 | — | 14.7 | 10.5 | — | 19.5 |
| GILLANDERS ARBUTHNOT LTD | 223 | 12.8 | 0.86 | 10.5 | 3.7 | 3.5 | 0.0 | 9.0 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 18.6 | 12.3 | 11 of 15 | 29% |
| P/B | 1.5 | 1.2 | 10 of 14 | 31% |
| ROCE | 9.7 | 8.4 | 6 of 14 | 62% |
| ROE | 8.2 | 10.7 | 9 of 14 | 39% |
| Debt / Equity | 0.7 | 0.3 | 12 of 14 | 15% |
| EBITDA margin | 16.6 | 20.6 | 9 of 14 | 39% |
| Revenue growth | 23.4 | 11.9 | 5 of 14 | 69% |
| Profit growth | 192.1 | 100.4 | 4 of 13 | 75% |
| Market cap | 49 | 223 | 11 of 15 | 29% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
